Simply Put: India's generosity during COVID-19

COVID-19: How safe are antiviral drugs for environment?

Both chloroquine and hydroxychloroquine, for example, pose serious chronic threat to the aquatic environment

COVID-19: World scrambles to procure dwindling medical supplies

India will need at least 27 million N95 masks, 1.6 million diagnostic kits in coming months, according to GlobalData 

More global trials for 3 COVID-19 drugs: WHO

The 3 drugs — used to treat malaria, cancer and immune disorders — will be tested on thousands of volunteer patients across 600 …

Union govt to consider Rs 65,560 crore corpus to handle future epidemics

India moved from managing travel-related cases to containing clusters and large outbreaks, Union health minister Harsh Vardhan said 

Ivermectin for COVID-19: Is India overusing

The medical fraternity is divided on its use amid lack of strong evidence of its success in treating COVID-19

COVID-19: All 4 repurposed drugs fail to show efficacy in WHO Solidarity Trial

The drugs failed to reduce mortality, hospitalisation stay and initiation of ventilation in admitted patients 

COVID-19: Why ICMR okayed hydroxychloroquine as preventive med

Hydroxychloroquine has been found to be effective against SARS-CoV-2 in laboratory studies

Ignoring WHO, ICMR to go ahead with HCQ for COVID workers

Indian studies yet to be completed; Indian Council of Medical Research says drug is safe

Why do we need to worry about antimicrobial resistance in the time of COVID-19?

As more and more antimicrobials are used to control the virus and the co-infections, this indiscriminate use will further increase AMR

Donald Trump is taking hydroxychloroquine to ward off COVID-19. Is that wise?

There is a 20% genetic difference between SARS-CoV-2 and previous SARS coronavirus, meaning we should not assume a drug shown to act against SARS …

Fatal bacterial infections may stem from COVID-19 therapies, AMR a concern: Study

Researchers have found that SARS-CoV-2 and bacteria in lungs may affect each other’s ability to cause damage and worsen the outcome in a …

The world needs pharmaceuticals from China and India to beat COVID-19

Chinese manufacturers make around 40% of all APIs used worldwide; China, India are the source of 75-80% of APIs imported to US

COVID-19: HCQ fails in first randomised controlled trials in France, China

Both studies show significant adverse effects of the drug on moderate and serious patients

COVID-19: Indiscriminate use of azithromycin may cause more harm than good

Antibiotic use during the novel coronavirus disease (COVID-19) needs to be guided by early diagnosis, proper characterisation of co-infections to …

COVID-19:Can Dexamethasone be the answer for critically ill patients

Can Dexamethasone be the answer for critically ill patients

The steroid reduced fatalities in COVID-19 patients on ventilators by a third, according to findings from a clinical trial in the island nation

Hydroxychloroquine for COVID-19: A new review of several studies shows flaws in research and no benefit

There are no controlled studies that assess the use of hydroxychloroquine to prevent the coronavirus

What is a clinical trial? A health policy expert explains

A controlled trial means study participants are split in two groups: One group is given the treatment and the other (the control group) is not

Chloroquine does not inhibit SARS-CoV-2 spread in human lung cells: Study

The drug stops the spread of the virus that causes COVID-19 in African green monkey kidney cells, but is ineffective in human lung cells